Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms

被引：0
|
作者：
Ke-Da Yu
Zhi-Ming Shao
机构：
[1] Ke-Da Yu and Zhi-Ming Shao are at the Breast Cancer Institute,
[2] Cancer Hospital,undefined
[3] Shanghai Medical College,undefined
[4] Fudan University,undefined
来源：
Nature Reviews Cancer | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：842 / 843
页数：1
相关论文
共 50 条
  • [31] Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry
    Jarvis, Joseph P.
    Peter, Arul Prakasam
    Shaman, Jeffrey A.
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [32] The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity
    Dinh, Jean C.
    Boone, Erin C.
    Staggs, Vincent S.
    Pearce, Robin E.
    Wang, Wendy Y.
    Gaedigk, Roger
    Leeder, James Steven
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 646 - 654
  • [33] The VeriDose CYP2D6 CNV Panel: A One-Well Solution for Copy Number and Hybrid Allele Detection of CYP2D6
    Everts, R. E.
    Lois, A.
    Nakorchevsky, A.
    Tao, H.
    Jackson, K.
    Rhodes, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1124 - 1125
  • [34] CYP2D6*10 genetic polymorphisms and Bisoprolol's pharmacokinetics
    Zhang, Zhi-guo
    Wang, Jing
    Li, Hong-ying
    Sun, Shu-bo
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 145 - 145
  • [35] The Impact of CYP2D6 Genetic Polymorphisms on Postoperative Morphine Consumption
    Candiotti, Keith A.
    Yang, Zongqi
    Rodriguez, Yiliam
    Crescimone, Andres
    Sanchez, Greys C.
    Takacs, Peter
    Medina, Carlos
    Zhang, Yanping
    Liu, Huanliang
    Gitlin, Melvin C.
    PAIN MEDICINE, 2009, 10 (05) : 799 - 805
  • [36] Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans
    Cespedes-Garro, Carolina
    Jimenez-Arce, Gerardo
    Naranjo, Maria-Eugenia G.
    Barrantes, Ramiro
    LLerena, Adrian
    REVISTA DE BIOLOGIA TROPICAL, 2014, 62 (04) : 1659 - 1671
  • [37] Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis
    Jadwiga Skrętkowicz
    Malgorzata Baranska
    Mariola Rychlik-Sych
    European Journal of Clinical Pharmacology, 2009, 65
  • [38] Impact of CYP2D6 genetic polymorphisms on tramadol use safety
    Diaz Pellicer, P.
    Aldea Perona, A. M.
    Perez Otero, M.
    Boronat Rigol, A.
    Coll Camenforte, S.
    Perez Lopez, E.
    De La Torre Fornell, R.
    Ventura Alemany, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 45 - 45
  • [39] Effect of CYP2D6 genetic polymorphisms on pharmacokinetics of tropisetron.
    Oh, D
    Kim, M
    Cho, J
    Lim, H
    Hong, K
    Chung, J
    Bae, K
    Yi, S
    Shin, S
    Jang, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P21 - P21
  • [40] Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis
    Skretkowicz, Jadwiga
    Baranska, Malgorzata
    Rychlik-Sych, Mariola
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (10) : 971 - 976
12345